Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 19/20 | 0.53 |
| ▸ | CA2 | P00918 | 19/20 | 0.53 |
| ▸ | CA13 | Q8N1Q1 | 4/20 | 0.53 |
| ▸ | CA7 | P43166 | 3/20 | 0.53 |
| ▸ | CA9 | Q16790 | 15/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23598928 | 0.92 | CA1 (0.53) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23598984 | 0.89 | CA1 (0.55) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23599176 | 0.87 | CA1 (0.69) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23599408 | 0.86 | CA1 (0.52) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23598986 | 0.83 | CA1 (0.58) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23599225 | 0.82 | CA1 (0.59) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23599177 | 0.82 | CA1 (0.56) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23598976 | 0.81 | CA1 (0.67) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23599215 | 0.81 | CA1 (0.62) | CA1CA2CA13CA7CA9 | |
| SCHEMBL23599229 | 0.80 | CA2 (0.55) | CA1CA2CA13CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021133915-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2021-07-01 | — | — | WO | disclosed |